- Details
- Written by IVN
- Category: Health News
Washington, DC - The U.S. Government has contributed $1 million to the International Atomic Energy Agency for a new project that will improve and streamline efforts to diagnose the Ebola virus in Africa. Of the total U.S. contribution, $650,000 is provided through the IAEA’s Peaceful Uses Initiative and $350,000 through other extra-budgetary contributions to the IAEA.
- Details
- Written by IVN
- Category: Health News
Sacramento, California - California Department of Public Health (CDPH) has been notified of seven confirmed cases of measles in patients from five different locations within California it was reported today by Dr. Ron Chapman, CDPH director and state health officer. Two Utah resident cases have also been confirmed and three additional California residents are also suspected to have measles and are under investigation.
- Details
- Written by USDA
- Category: Health News
Washington, DC - Fresh Food Manufacturing, a Freedom, Pennsylvania establishment, is recalling approximately 35,865 pounds of chili products due to misbranding and an undeclared allergen, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced today. The product contains peanuts, a known allergen which is not declared on the product label.
- Details
- Written by USDA
- Category: Health News
Torrance, California - Jinon Corporation, dba Nijiya Market, a Torrance, California establishment, is recalling approximately 359 pounds of frozen boneless beef products produced in Japan that were not presented at the U.S. point of entry for inspection, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced today. Without the benefit of full inspection, a possibility of adverse health consequences exists.
- Details
- Written by IVN
- Category: Health News
Washington, DC - Researchers from the National Institutes of Health have entered into an agreement with biotechnology company Vtesse, Inc., of Gaithersburg, Maryland, to develop treatments for Niemann-Pick disease type C (NPC) and other lysosomal storage disorders.
- Details
- Written by IVN
- Category: Health News
San Francisco, California - “Our mission is to accelerate the development of stem cell therapies for patients with unmet medical needs. Today, in officially launching the first three programs under CIRM 2.0, we have boldly reaffirmed our commitment to continuously seek new and innovative ways to better serve that mission,” says Dr. C. Randal Mills, the President and CEO of CIRM, California’s stem cell agency.
Page 341 of 374
